-
AI Empowers Patients to Navigate Cancer CareAACR patient advocate forum describes how AI tools can help advance research and educate patients.
by Darlene Dobkowski
-
COVID-19 Vaccines Linked to Extended Survival in Lung Cancer and MelanomaIn addition to protection from the coronavirus, mRNA-based COVID-19 vaccines may strengthen the effectiveness of immunotherapy.
by Sandra Gordon
-
Physical Activity Helps Alleviate Side Effects from Cancer TreatmentExercise programs and individualized support can help survivors of all fitness levels reap the benefits of movement.
by Erin O’Donnell
-
Questions to Ask About the Second-most Common Skin CancerCutaneous squamous cell carcinoma is usually curable, but not always.
by Alexandra Frost
-
First-ever Treatment Approved for Smoldering Myeloma Comes With QuestionsDoctors urge patients to weigh benefits and risks after the FDA approved a treatment for high-risk smoldering myeloma.
by Kyle Bagenstose
-
FDA Approves Immunotherapy for Cutaneous Squamous-cell CarcinomaAdding immunotherapy to treatment improves outcomes for people with a high-risk form of this common skin cancer.
by Sandra Gordon
-
Cancer Today Editors’ Picks: 2025The editors share the most impactful Cancer Today stories from 2025.
-
2025: The Year in Cancer NewsThe editors of Cancer Today share impactful reporting and writing on cancer research and care from 2025.
by Cancer Today staff
-
Immunotherapy Approval Marks Progress in Small Cell Lung CancerImmune checkpoint inhibitor improves survival in people with limited-stage small cell lung cancer.
by Taneia Surles
-
Limiting Surgery in Early-stage Breast CancerClinical trial presented at SABCS finds some patients may safely skip sentinel lymph node biopsy.
by Thomas Celona
A recently approved drug that targets RAS proteins meaningfully improves outcomes for people with this difficult-to-treat cancer.
by Sandra Gordon
Bring On the WavesA surfer’s love for the ocean guides her through breast cancer treatment and beyond.
by Cameron Walker
Does Exercise Benefit Children With Cancer?New guidelines recommend children and adolescents with cancer get regular physical activity to mitigate side effects from treatment.
by Erin O’Donnell
Can the CYP2D6 Gene Affect Tamoxifen’s Effectiveness?A recent analysis examined whether CYP2D6 metabolism influences tamoxifen response. The answer isn’t entirely clear.
by Ashley P. Taylor
-
AACR OMB Statement and Call to ActionThe AACR is deeply concerned that proposed OMB regulations would disrupt federal research grant giving, severely weakening a program that has supported American medical innovation for decades.
-
AACR Cancer Disparities Progress ReportThe AACR Cancer Disparities Progress Report 2026 highlights recent progress in reducing cancer disparities and emphasizes the continued need for transformative research.
Cancer Research at a Crossroads
